CA2408315A1 - Aminoacyl-arnt synthetases - Google Patents

Aminoacyl-arnt synthetases Download PDF

Info

Publication number
CA2408315A1
CA2408315A1 CA002408315A CA2408315A CA2408315A1 CA 2408315 A1 CA2408315 A1 CA 2408315A1 CA 002408315 A CA002408315 A CA 002408315A CA 2408315 A CA2408315 A CA 2408315A CA 2408315 A1 CA2408315 A1 CA 2408315A1
Authority
CA
Canada
Prior art keywords
polypeptide
polynucleotide
atrs
seq
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002408315A
Other languages
English (en)
Inventor
Henry Yue
Tom Y. Tang
Chandra Patterson
Ameena R. Gandhi
Catherine M. Tribouley
Ernestine A. Lee
Monique G. Yao
Olga Bandman
Dyung Alina M. Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2408315A1 publication Critical patent/CA2408315A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des aminoacyl-ARNt synthétases humaines (ATRS), ainsi que des polynucléotides permettant d'identifier ces ATRS et codant pour ces dernières. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes, et des antagonistes. L'invention concerne enfin des méthodes de diagnostic, de traitement ou de prévention de troubles associés à une expression aberrante d'ATRS.
CA002408315A 2000-05-25 2001-05-22 Aminoacyl-arnt synthetases Abandoned CA2408315A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US20724800P 2000-05-25 2000-05-25
US60/207,248 2000-05-25
US20879100P 2000-06-01 2000-06-01
US60/208,791 2000-06-01
US21058500P 2000-06-08 2000-06-08
US60/210,585 2000-06-08
PCT/US2001/016808 WO2001090330A2 (fr) 2000-05-25 2001-05-22 Aminoacyl-arnt synthetases

Publications (1)

Publication Number Publication Date
CA2408315A1 true CA2408315A1 (fr) 2001-11-29

Family

ID=27395048

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002408315A Abandoned CA2408315A1 (fr) 2000-05-25 2001-05-22 Aminoacyl-arnt synthetases

Country Status (5)

Country Link
EP (1) EP1290148A2 (fr)
JP (1) JP2004510407A (fr)
AU (1) AU2001263404A1 (fr)
CA (1) CA2408315A1 (fr)
WO (1) WO2001090330A2 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2431493A1 (fr) * 2000-12-15 2002-08-01 Incyte Genomics, Inc. Aminoacyl arnt synthetases
AU2009257538A1 (en) 2008-06-11 2009-12-17 Atyr Pharma, Inc. Thrombopoietic activity of tyrosyl-tRNA synthetase polypeptides
EP3176261A1 (fr) 2008-06-26 2017-06-07 aTyr Pharma, Inc. Compositions et procédés comprenant des glycyl-arnt synthétases ayant des activités biologiques non canoniques
WO2010099477A2 (fr) 2009-02-27 2010-09-02 Atyr Pharma, Inc. Motifs structuraux de polypeptides associés à une activité de signalisation cellulaire
EP3255146B1 (fr) 2009-03-16 2019-05-15 Pangu Biopharma Limited Compositions et procedes comprenant des variants d'epissage d'histidyl-arnt synthetase presentant des activites biologiques non canoniques
ES2560674T3 (es) 2009-03-31 2016-02-22 Atyr Pharma, Inc. Composiciones y procedimientos que comprenden aspartil-ARNt sintetasas con actividades biológicas no canónicas
US8828395B2 (en) 2009-12-11 2014-09-09 Atyr Pharma, Inc. Antibodies that bind tyrosyl-tRNA synthetases
CA2783731C (fr) 2009-12-11 2018-03-27 Atyr Pharma, Inc. Aminoacyl-arnt synthetases destinees a moduler une inflammation
WO2011072266A2 (fr) * 2009-12-11 2011-06-16 Atyr Pharma, Inc. Aminoacyl-arnt synthétases destinées à moduler l'hématopoïèse
AU2011248625B2 (en) 2010-04-26 2017-01-05 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
CN108165537A (zh) 2010-04-27 2018-06-15 Atyr医药公司 与苏氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
CA2797362C (fr) 2010-04-27 2020-12-08 Atyr Pharma, Inc. Decouverte innovante de compositions therapeutiques, de diagnostic et d'anticorps se rapportant a des fragments proteiques d'isoleucyl arnt synthetases
CA2797271C (fr) 2010-04-28 2021-05-25 Atyr Pharma, Inc. Compositions therapeutiques, diagnostiques et d'anticorps a base de fragments de proteines d'aminoacyl-arnt synthetases
AU2011248490B2 (en) 2010-04-29 2016-11-10 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
AU2011248457B2 (en) 2010-04-29 2017-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases
US9034321B2 (en) 2010-05-03 2015-05-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
EP2566516B1 (fr) 2010-05-03 2019-07-03 aTyr Pharma, Inc. Découverte innovante de compositions thérapeutiques, de diagnostic et d'anticorps liées à des fragments protéiques de séryle-arnt synthétases
CA2797277C (fr) 2010-05-03 2021-02-23 Atyr Pharma, Inc. Decouverte innovante de compositions therapeutiques, de diagnostic et d'anticorps liees a des fragments proteiques d'arginyle-arnt synthetases
EP2566496B1 (fr) 2010-05-03 2018-02-28 aTyr Pharma, Inc. Découverte innovante de compositions thérapeutiques, diagnostiques et à base d'anticorps liées des fragments protéiques de méthionyl-arnt-synthétases
CA2798301C (fr) 2010-05-04 2020-09-15 Atyr Pharma, Inc. Decouverte innovante de compositions therapeutiques, diagnostiques et a base d'anticorps liees a des fragments proteiques de glutamyl-prolyl-arnt-synthetases
AU2011248101B2 (en) 2010-05-04 2016-10-20 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex
CA2799197C (fr) 2010-05-14 2019-10-29 Atyr Pharma, Inc. Decouverte de compositions inedites de nature therapeutique, diagnostique et a base d'anticorps contenant des fragments proteiques de phenylalanyl-beta-arnt synthetases
AU2011256366C1 (en) 2010-05-17 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
JP6046607B2 (ja) 2010-05-27 2016-12-21 エータイアー ファーマ， インコーポレイテッド グルタミニルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
WO2011153277A2 (fr) 2010-06-01 2011-12-08 Atyr Pharma, Inc. Découverte innovante de compositions thérapeutiques, diagnostiques, et d'anticorps associés à des fragments de protéine de lysyl-tarn synthétases
US8999321B2 (en) 2010-07-12 2015-04-07 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
AU2011289833C1 (en) 2010-07-12 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Histidyl-tRNA synthetases
US8969301B2 (en) 2010-07-12 2015-03-03 Atyr Pharma Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-tRNA synthetases
AU2011289831C1 (en) 2010-07-12 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
EP2608801B1 (fr) 2010-08-25 2019-08-21 aTyr Pharma, Inc. Découverte innovante de compositions thérapeutiques, diagnostiques et d'anticorps associées à des fragments protéiniques des tyrosyl-arnt synthétases
JP6039566B2 (ja) 2010-10-06 2016-12-07 エータイアー ファーマ， インコーポレイテッド 治療用、診断用および抗体組成物に関連したトリプトファニルｔＲＮＡ合成酵素のタンパク質フラグメントの革新的発見
WO2013022982A2 (fr) 2011-08-09 2013-02-14 Atyr Pharma, Inc. Polypeptides tyrosyl-arnt synthétase pégylés
US9822353B2 (en) 2011-12-06 2017-11-21 Atyr Pharma, Inc. PEGylated aspartyl-tRNA synthetase polypeptides
US9816084B2 (en) 2011-12-06 2017-11-14 Atyr Pharma, Inc. Aspartyl-tRNA synthetases
WO2013115926A2 (fr) 2011-12-29 2013-08-08 Atyr Pharma, Inc. Conjugués aspartyl-arnt synthétase-fc
NZ628126A (en) 2012-02-16 2016-10-28 Atyr Pharma Inc Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
DK3460054T3 (da) 2013-03-15 2021-01-18 Atyr Pharma Inc Histidyl-tRNA-syntetase-Fc-konjugater
CA3060514A1 (fr) 2017-04-20 2018-10-25 Atyr Pharma, Inc. Compositions et procedes pour le traitement d'inflammation pulmonaire
CN109266734A (zh) * 2018-09-25 2019-01-25 深圳市人民医院 自身免疫性疾病诊断试剂盒和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5759833A (en) * 1994-05-27 1998-06-02 Cubist Pharmaceuticals, Inc. Human isoleucyl-tRNA synthetase proteins, nucleic acids and tester strains comprising same

Also Published As

Publication number Publication date
AU2001263404A1 (en) 2001-12-03
EP1290148A2 (fr) 2003-03-12
WO2001090330A2 (fr) 2001-11-29
WO2001090330A3 (fr) 2002-08-08
JP2004510407A (ja) 2004-04-08

Similar Documents

Publication Publication Date Title
CA2408315A1 (fr) Aminoacyl-arnt synthetases
US20040018505A1 (en) Aminoacyl trna synthetases
US20030215827A1 (en) Aminoacyl trna synthetases
US20040048290A1 (en) Aminoacyl trna synthetases
CA2431493A1 (fr) Aminoacyl arnt synthetases
CA2380317A1 (fr) Synthetases humaines
WO2001010903A2 (fr) Proteases et inhibiteurs de proteases
EP1212436A2 (fr) Proteines phosphatase et proteines kinase
EP1498480A2 (fr) Enzymes hydrolitiques humaines
WO2001032888A2 (fr) Molecules humaines de la transferase
CA2409315A1 (fr) Proteine-phosphatases
CA2410953A1 (fr) Adenylyl et guanylyl cyclases
US20020160950A1 (en) Cytochrome P450 variant
CA2398003A1 (fr) Phosphodiesterases
CA2413810A1 (fr) Aminoacyl arnt synthetases
EP1206553A2 (fr) Proteines d'isomerase
EP1183370A2 (fr) Proteines d'oxydoreductase
WO2000073334A2 (fr) Tri de nexines
CA2381338A1 (fr) Lyases humaines
CA2425767A1 (fr) Lipocalines
WO2001044445A2 (fr) Lyases humaines et proteines associees
CA2406264A1 (fr) Phosphatases de proteines
WO2000078952A2 (fr) Proteines du metabolisme de l'arn
EP1477564A2 (fr) Synthetases humaines
US20030121061A1 (en) Human lyases

Legal Events

Date Code Title Description
FZDE Dead